Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum ...

Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress ...

The Gates Medical Research Institute (MRI) has appointed Charles Wells as Chief Medical Officer (CMO) and Head of Medical ...

Johnson & Johnson (J&J) has announced results from the final analysis of the phase 3 PROTEUS study showing that Erleada ...

Pfizer and Innovent will co-develop four programmes globally and share the development costs. The companies will ...

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by ...

June is PRIDE month and EMA starts a two-month celebration of diversity and inclusion in science and healthcare, leading up ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the treatment of androgenetic alopecia, into phase 3 trials. PP405 is a ...

For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative ...

Eli Lilly is to acquire LimmaTech Biologics and Vaccine Company. Along with its acquisition of Curevo, the companies will ...

The National Institute for Health and Care Excellence (NICE) has recommended Genmab UK’s Tivdak (tisotumab vedotin) for ...

UK market access needs the right conditions nationally, along with subnational investment and delivery locally ...